Does Adding Transdermal Nitroglycerine to Other Therapies Used for Management of Left-sided Congestive Heart Failure in Dogs Speed the Resolution of Clinical Signs?
<p>There is very weak veterinary clinical and experimental evidence based upon a limited number of studies to indicate that adding transdermal nitroglycerine to other therapies used for management of left-sided congestive heart failure in dogs speeds the resolution of clinical signs.</p>...
Main Authors: | Jenefer R Stillion, Søren R Boysen |
---|---|
Format: | Article |
Language: | English |
Published: |
RCVS Knowledge
2017-12-01
|
Series: | Veterinary Evidence |
Subjects: | |
Online Access: | https://veterinaryevidence.org/index.php/ve/article/view/115 |
Similar Items
-
THE EFFECT OF TRANSDERMAL NITROGLYCERINE ON ANALGESIC EFFECT OF INTRATHECAL SUFENTANIL IN LOWER EXTREMITY SURGERY
by: P KASHEF
Published: (2003-12-01) -
A pilot study investigating circulating trimethylamine N‐oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure
by: Emily T. Karlin, et al.
Published: (2019-01-01) -
Erratum to: Does Adding Transdermal Nitroglycerine to Other Therapies Used for Management of Left-sided Congestive Heart Failure in Dogs Speed the Resolution of Clinical Signs?
by: Jenefer R Stillion, et al.
Published: (2018-02-01) -
“Playboy Bunny” Sign of Congestive Heart Failure
by: Fukunori Kinjo, et al.
Published: (2011-05-01) -
Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis
by: Shi J, et al.
Published: (2018-12-01)